90042373 - DXT

Information

• Trademark
• 90042373

• Source

• Serial Number

  90042373

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 08, 2020
  4 years ago

• Transaction Date

  September 06, 2022
  2 years ago

• Status Date

  September 05, 2022
  2 years ago

• Published for Opposition Date

  December 15, 2020
  4 years ago

• Location Date

  August 03, 2021
  3 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  KERTGATE, AMY L

• Attorney Docket Number

  363810050001

  Attorney Name

  Kristen McCallion

  Law Office Assigned Location Code

  M40

• Owners

  • Domp e Farmaceutici SpA

Case File Statements

• GS0091: downloadable computer software for use in identifying new drugs; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data for use in making informed medical decisions; downloadable virtual reality software for medical teaching; downloadable virtual reality software for medical screening; downloadable computer software platforms for use in database management in the field of medicine; downloadable computer application software for mobile phones, namely, software for use in identifying new drugs; downloadable computer software using artificial intelligence for use in identifying new drugs; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems
• GS0051: Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceutical preparations; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of rare ocular disorders or diseases; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold preparations; pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of rare tissue and organ transplantation-related diseases and conditions; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations, namely, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations, namely, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems
• GS0421: software as a service (SAAS) services featuring software using artificial intelligence for use in identifying new drugs; providing a website featuring non-downloadable software using artificial intelligence for use in identifying new drugs; research in the field of artificial intelligence; design and development of computer software in the field of medicine; design and development of virtual reality software for medical screening; design and development of virtual reality software for medical teaching

Case File Event Statements

• 9/6/2022 - 2 years ago

  27 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 9/5/2022 - 2 years ago

  26 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 2/4/2022 - 2 years ago

  25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/2/2022 - 3 years ago

  24 - SOU EXTENSION 1 GRANTED Type: EX1G

• 2/2/2022 - 3 years ago

  23 - SOU EXTENSION 1 FILED Type: EXT1

• 2/2/2022 - 3 years ago

  22 - TEAS EXTENSION RECEIVED Type: EEXT

• 8/3/2021 - 3 years ago

  21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/24/2021 - 3 years ago

  20 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 6/3/2021 - 3 years ago

  19 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB

• 6/2/2021 - 3 years ago

  18 - ASSIGNED TO PETITION STAFF Type: APET

• 5/25/2021 - 3 years ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/25/2021 - 3 years ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/29/2021 - 3 years ago

  15 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 1/8/2021 - 4 years ago

  14 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 12/15/2020 - 4 years ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/15/2020 - 4 years ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/25/2020 - 4 years ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/9/2020 - 4 years ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/7/2020 - 4 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/6/2020 - 4 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/6/2020 - 4 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/20/2020 - 4 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/20/2020 - 4 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/20/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/16/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/6/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/11/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP